BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1644930)

  • 1. Absence of hereditary p53 mutations in 10 familial leukemia pedigrees.
    Felix CA; D'Amico D; Mitsudomi T; Nau MM; Li FP; Fraumeni JF; Cole DE; McCalla J; Reaman GH; Whang-Peng J
    J Clin Invest; 1992 Aug; 90(2):653-8. PubMed ID: 1644930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia.
    Felix CA; Nau MM; Takahashi T; Mitsudomi T; Chiba I; Poplack DG; Reaman GH; Cole DE; Letterio JJ; Whang-Peng J
    J Clin Invest; 1992 Feb; 89(2):640-7. PubMed ID: 1737852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of hereditary mutations in exons 5 through 9 of the p53 gene and exon 24 of the neurofibromin gene in families with glioma.
    van Meyel DJ; Ramsay DA; Chambers AF; Macdonald DR; Cairncross JG
    Ann Neurol; 1994 Jan; 35(1):120-2. PubMed ID: 8285583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms.
    Malkin D; Jolly KW; Barbier N; Look AT; Friend SH; Gebhardt MC; Andersen TI; Børresen AL; Li FP; Garber J
    N Engl J Med; 1992 May; 326(20):1309-15. PubMed ID: 1565144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence for germline mutations in exons 5-9 of the p53 gene in 25 breast cancer families.
    Warren W; Eeles RA; Ponder BA; Easton DF; Averill D; Ponder MA; Anderson K; Evans AM; DeMars R; Love R
    Oncogene; 1992 May; 7(5):1043-6. PubMed ID: 1570151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
    Birch JM; Hartley AL; Tricker KJ; Prosser J; Condie A; Kelsey AM; Harris M; Jones PH; Binchy A; Crowther D
    Cancer Res; 1994 Mar; 54(5):1298-304. PubMed ID: 8118819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Li-Fraumeni syndrome].
    Frebourg T
    Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.
    Srivastava S; Zou ZQ; Pirollo K; Blattner W; Chang EH
    Nature; 1990 Dec 20-27; 348(6303):747-9. PubMed ID: 2259385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias.
    Wei S; Kito K; Miyoshi A; Matsumoto S; Kauzi A; Aramoto T; Abe Y; Ueda N
    J Exp Clin Cancer Res; 2002 Sep; 21(3):389-96. PubMed ID: 12385583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Germline mutations of the p53 gene].
    Frebourg T
    Pathol Biol (Paris); 1997 Dec; 45(10):845-51. PubMed ID: 9769948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel germline mutation of the p53 tumor suppressor gene in a child with incidentally discovered adrenal cortical carcinoma.
    Grayson GH; Moore S; Schneider BG; Saldivar V; Hensel CH
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):341-7. PubMed ID: 7978053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases.
    Yamada Y; Yoshida T; Hayashi K; Sekiya T; Yokota J; Hirohashi S; Nakatani K; Nakano H; Sugimura T; Terada M
    Cancer Res; 1991 Nov; 51(21):5800-5. PubMed ID: 1933850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer.
    Lehman TA; Haffty BG; Carbone CJ; Bishop LR; Gumbs AA; Krishnan S; Shields PG; Modali R; Turner BC
    Cancer Res; 2000 Feb; 60(4):1062-9. PubMed ID: 10706125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of p53 gene in gastric carcinoma in Taiwan.
    Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
    Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel p53 germline alteration identified in a late onset breast cancer kindred.
    Sun XF; Johannsson O; Håkansson S; Sellberg G; Nordenskjöld B; Olsson H; Borg A
    Oncogene; 1996 Jul; 13(2):407-11. PubMed ID: 8710380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A germ line mutation in exon 5 of the p53 gene in an extended cancer family.
    Law JC; Strong LC; Chidambaram A; Ferrell RE
    Cancer Res; 1991 Dec; 51(23 Pt 1):6385-7. PubMed ID: 1933902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of p53 gene mutations in human leukemia by PCR-SSCP analysis and direct nucleotide sequencing.
    Wang R; Yu Z; Gu J; Li D; Wang M; Cao Y
    Chin Med J (Engl); 1998 Apr; 111(4):339-42. PubMed ID: 10374399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
    Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sporadic mutations of the p53 gene in multiple myeloma and no evidence for germline mutations in three familial multiple myeloma pedigrees.
    Willems PM; Kuypers AW; Meijerink JP; Holdrinet RS; Mensink EJ
    Leukemia; 1993 Jul; 7(7):986-91. PubMed ID: 8321049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.